Inhibition of low molecular weight heparin by protamine chloride in vivo.
To determine the antagonization of anticoagulant and lipolytic effects of a low molecular weight [LMW] heparin preparation protamine chloride was given intravenously after i.v. injection of LMW or normal heparin. The effects of normal heparin on factor Xa, thrombin, aPTT, lipoprotein [LPL] and hepatic triglyceride lipase [HTGL] activities were neutralized immediately by i.v. protamine. The inhibition of thrombin and aPTT by LMW heparin were also abolished, whereas the effects on LPL and HTGL were counteracted to 80% and on factor Xa only to 40% by i.v. protamine chloride. No rebound of the anticoagulant or lipolytic effect was detected. It is assumed that haemorrhagic complication during therapy can be antagonized by protamine chloride. The incomplete inhibitory effect of protamine chloride on LPL, HTGL and factor Xa activities of LMW heparin indicate that protamine chloride requires more than 14 saccharide units in the heparin molecule for interaction.
D000328:Adult; D002851:Chromatography, High Pressure Liquid; D005170:Factor X / Q000502:physiology; D015951:Factor Xa; D006493:Heparin; D006494:Heparin Antagonists / Q000494:pharmacology*; D006801:Humans; D008049:Lipase / Q000378:metabolism; D008074:Lipoproteins / Q000378:metabolism; D008099:Liver / Q000201:enzymology; D008297:Male; D008970:Molecular Weight; D010314:Partial Thromboplastin Time; D011479:Protamines / Q000494:pharmacology*; D013918:Thrombin Time
D006494:Heparin Antagonists; D008074:Lipoproteins; D011479:Protamines; D005170:Factor X; D006493:Heparin; D008049:Lipase; D015951:Factor Xa